Lv11
76 积分 2025-01-11 加入
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
1小时前
已完结
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
2小时前
已完结
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
2小时前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
3个月前
已完结
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
3个月前
已完结
Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis
3个月前
已完结
Application of postoperative adjuvant radiotherapy in limited-stage small cell lung cancer: A systematic review and meta-analysis
7个月前
已完结
Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure
8个月前
已完结
The chances of hepatic resection curing hepatocellular carcinoma
8个月前
已完结
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma: Erratum
8个月前
已完结
皖公网安备34019202002308
